NKGN: NKGen Biotech Company Short-Term Debt

This chart of NKGen Biotech, Inc. (NKGN) asset value demonstrates the dynamics of a company developing advanced treatments for dementia and oncology through immune cell modification. The current figure is 0.00. The business faces clinical trial uncertainty and a funding shortage, while operational processes are strictly limited by FDA medical standards regarding biological waste processing.

NKGN NKGen Biotech Company Short-Term Indebtedness (02/21/2024 - 03/15/2025)

Analytical breakdowns for NKGen Biotech, Inc.

- current quotes and average value forecast:
Price Chart NKGen Biotech|NKGN - Fair Value Consensus
- market capitalization information:
Market Value NKGen Biotech, Inc.|NKGN - Total Enterprise Value
- shareholders' equity book value data:
Net Assets per Single Share NKGen Biotech|NKGN - Accounting Capitalization|Market Value to Book Value Ratio nkgenbiotech.com|NKGN - Company Total Assets
- debt and liquidity details:
Total Debt to Capital NKGen Biotech, Inc.|NKGN - Long-Term Indebtedness to Equity|Short-Term Debt to Capital NKGen Biotech, Inc.|NKGN - Company Cumulative Debt|Debt to Book Capitalization Ratio NKGen Biotech, Inc.|NKGN - Company Long-Term Indebtedness|Company Current Liabilities NKGen Biotech|Quick Ratio nkgenbiotech.com
- earnings and multiples data:
NKGN - Company Net Income
Basic company analysis:NKGN - NKGen Biotech

This metric measures total liabilities with a maturity of up to one year, allowing for the rapid identification of liquidity risks and phases of accumulating credit pressure. By analyzing the level of short-term obligations, an investor assesses the financial stability of NKGen Biotech, Inc. (NKGN), which is critical for sustaining costly research and development in the field of Alzheimer's and Parkinson's disease therapies using NK cells.

Direct competitors

BIIB - Company Short-Term Debt|Company Short-Term Loans and Borrowings NBIX (Neurocrine)|Regencell (RGC) - Company Short-Term Debt|Short-Term Debt Axsome Corp (AXSM)|Company Short-Term Debt ACADIA Pharmaceuticals|Company Short-Term Indebtedness XENE (xenon-pharma.com)|Company Short-Term Debt Viking Therapeutics, Inc. (VKTX)|Company Short-Term Debts Supernus Pharmaceuticals, Inc. (SUPN)|Company Short-Term Debts CPRX (Catalyst Pharmaceuticals Inc)|Short-Term Indebtedness Denali Corp|Harmony Biosciences - Company Short-Term Debts|Short-Term Debt biohavenpharma.com|Amylyx Pharmaceuticals, Inc. (AMLX) - Company Short-Term Debt|Company Short-Term Indebtedness TRVI|Company Current Liabilities PRAX|AVXL: Company Short-Term Loans and Borrowings|Company Short-Term Debts CBLL|Company Short-Term Debt PRTA (Prothena Corporation plc)|Company Short-Term Debts ALEC (Alector)|Short-Term Debt Volume Annexon Biosciences (ANNX)|OMER - Company Short-Term Debt|Short-Term Debt Neurogene Therapeutics|ACIU (AC Immune) - Company Current Liabilities|VYGR: Amount of Current Liabilities|NMRA (Neumora Therapeutics, Inc.) - Company Short-Term Debts|Short-Term Debt Scilex Holding SCLX|Company Short-Term Debts TVGN|Company Current Liabilities alphacognition.com ACOG|Company Short-Term Debts CGTX (Cognition Therapeutics, Inc.)|Company Short-Term Loans and Borrowings IKT|SAVA: Company Current Liabilities|Company Short-Term Loans and Borrowings ASRT (Assertio Holdings, Inc.)|COYA: Company Short-Term Debts|VTGN - Short-Term Debt Volume|Company Short-Term Debt Ovid Therapeutics Inc|Company Short-Term Indebtedness ABOS (acumenpharm.com)|Company Short-Term Debts CRVO|Company Current Liabilities alteritytherapeutics.com ATHE|Clene - Company Current Liabilities|Short-Term Debt Volume PepGen Inc (PEPG)|JUNS - Company Short-Term Debt|RLMD (relmada.com) - Company Short-Term Indebtedness|Annovis Bio (ANVS) - Company Short-Term Debt|Grace Therapeutics (GRCE) - Company Short-Term Debts|AIFF (Firefly Neuroscience Inc) - Company Short-Term Debts|KLTO - Short-Term Indebtedness|Company Short-Term Debt NeuroSense Therapeutics (NRSN)|revivapharma.com - Company Short-Term Indebtedness|Company Short-Term Debt MetaVia MTVA|NRXS: Company Short-Term Indebtedness|Helius Medical Technologies Inc. - Company Short-Term Debts|Short-Term Debt Passage Bio, Inc.|NEUP (bionomics.com.au) - Company Current Liabilities|minervaneurosciences.com (NERV) - Company Short-Term Debts|Company Short-Term Debt Athira Pharma|ADXN: Company Short-Term Loans and Borrowings|Company Short-Term Debt Alzamend Neuro, Inc. (ALZN)|CYCN - Short-Term Debt|Company Short-Term Debt Protagenic Therapeutics, Inc. PTIX|KTTA: Company Short-Term Indebtedness|CRGT - Company Short-Term Debt|ATXI - Company Short-Term Debts|BCLI: Company Short-Term Debts|Short-Term Indebtedness Cara Therapeutics Inc CARA|CHRO (Chromocell Therapeutics) - Company Short-Term Debts|Short-Term Debt Eliem ELYM|Company Short-Term Debt Intra-Cellular Therapies (ITCI)|Longboard Pharmaceuticals Inc - Company Short-Term Indebtedness|Marinus - Company Current Liabilities|Company Short-Term Loans and Borrowings NRBO|Sage Therapeutics, Inc. - Company Short-Term Debts|SNPX: Company Short-Term Debt|TRVN: Company Short-Term Debts|VIGL - Short-Term Debt Volume|Company Short-Term Debt Anew Medical, Inc.|Short-Term Debt Cerevel Corp CERE